Klotho is one of the most consistent predictors of all-cause mortality and cognitive decline in human aging research. Here's what the 2026 evidence shows about Klotho biology, how to test your levels, and the interventions that move the needle.
In 1997, Japanese researchers identified a mouse with a single gene defect that produced a phenotype of dramatically accelerated aging — premature death by 8 weeks (compared to normal mouse lifespan of 2+ years), severe arteriosclerosis, osteoporosis, infertility, cognitive impairment, and skin atrophy. They named the gene Klotho, after the Greek mythological figure who spins the thread of life. Conversely, mice engineered to overexpress Klotho lived 20–30% longer than wild-type controls and remained cognitively intact through old age.
In the decades since, Klotho has emerged as one of the most consistent and biologically powerful aging-relevant proteins identified. It functions as a co-receptor for FGF23 in phosphate regulation, but its longevity effects appear to involve much more — including direct cognitive enhancement that crosses the blood-brain barrier without requiring the protein itself to enter the brain.
This article summarizes the 2026 state of Klotho research, how to test your levels, and the interventions that meaningfully change them.
Klotho exists in three biologically active forms:
The longevity-relevant form is secreted Klotho. Higher circulating levels correlate strongly with:
The Italian InCHIANTI cohort showed that older adults in the highest Klotho quartile had a 78% reduction in all-cause mortality over 6 years compared to the lowest quartile, after adjustment for age, sex, comorbidities, and inflammatory markers.
Klotho production decreases with age in healthy adults, declining roughly 30–50% between age 40 and age 80. The decline accelerates with kidney dysfunction, chronic inflammation, hypertension, and chronic stress. Several mechanisms appear to drive the decline: reduced KL gene transcription, increased Klotho clearance, and damage to the kidney cells that are the primary source.
Serum Klotho can be measured by ELISA. Reference ranges vary by lab; typical adult values are 600–900 pg/mL with substantial individual variation.
In 2026, several specialty labs offer Klotho testing:
A single Klotho measurement is less actionable than a trend over time. The clinically interesting use case is measuring at baseline and after intervention (12+ weeks).
Several interventions have been shown to increase circulating Klotho in human studies:
The most consistent intervention. 3–6 months of regular aerobic exercise (3–5 sessions per week, moderate intensity) increases serum Klotho 15–40% in published studies. The effect appears dose-dependent and is larger in previously sedentary individuals.
Caloric restriction increases Klotho expression in mouse and limited human studies. The effect of time-restricted eating on Klotho specifically is less well-studied but appears positive.
Klotho expression in kidney cells is partially vitamin D-dependent. Correcting vitamin D deficiency (achieving 25-OH vitamin D ≥30 ng/mL) increases circulating Klotho.
As an Amazon Associate, Stacking Years earns from qualifying purchases.
1–2 caps daily with a fat-containing meal
5,000 IU D3 softgels — dose to achieve 25-OH D ≥40 ng/mL. Vitamin D3 sufficiency is one of the most actionable interventions for raising circulating Klotho levels.
Rating: 4.8/5
View on Amazon · Affiliate link
Chronic psychological stress lowers Klotho. Meditation, sleep optimization, and reduction of allostatic load increase Klotho in small intervention studies.
Multiple studies show statin therapy increases circulating Klotho, possibly through reduced inflammation. This is one of the underrecognized benefits of statin therapy in older adults.
Limited human data, but curcumin, resveratrol, and EGCG (green tea catechin) have shown Klotho-increasing effects in small studies.
Several biotechnology companies are developing recombinant Klotho or Klotho-modulating drugs. As of 2026:
None has reached late-phase trials yet. The most likely first clinical approval would be in chronic kidney disease, with cognitive and cardiovascular indications following.
Without waiting for therapeutics, the evidence-supported practical approach:
1. Test serum Klotho if available
2. Maintain vitamin D 25-OH at 40–60 ng/mL
3. Aerobic exercise 4+ times per week, including some Zone 2 work
4. Avoid chronic inflammation (CRP, ESR, ferritin trending high)
5. Manage blood pressure aggressively if hypertensive
6. Consider statin if cardiovascular risk indicates (additional Klotho benefit)
7. Sleep 7+ hours consistently
8. Avoid smoking; minimize alcohol
For more on the molecular mechanisms of aging that intersect with Klotho, see The Hallmarks of Aging: A 2026 Update and Cellular Senescence and Healthspan.
Should I take a "Klotho supplement"?
No oral Klotho supplement has demonstrated bioavailability — Klotho is a protein and would be digested. Products marketed as "Klotho" supplements are not what they claim.
Can I increase my Klotho enough to live longer?
The exercise data alone supports meaningful Klotho elevation. Whether the elevation translates to lifespan extension in humans is not yet proven, but the observational mortality association is among the strongest in aging research.
Is Klotho testing useful?
For research-curious users with disposable income, yes — particularly to track response to interventions. For most people, the practical interventions don't require testing.